Status:
UNKNOWN
Osteoporosis and Haemophilia
Lead Sponsor:
PD Dr. Andreas Strauß
Collaborating Sponsors:
Bayer
Conditions:
Osteoporosis
Haemophilia
Eligibility:
MALE
18+ years
Brief Summary
The aim of this study is to evaluate the prevalence of osteoporosis in adult patients with haemophilia.
Detailed Description
The aim of this study is to evaluate the prevalence of osteoporosis in adult patients with haemophilia. Subsequently, the ascertained prevalence of osteoporosis in patients with haemophilia will be co...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years of age) suffering from mild (FVIII or IX \>5 %), moderate (FVIII or IX 1-5 %) or severe (FVIII or IX \<1 %) haemophilia A or B
- Submitted written consent to participate in the study
Exclusion
- Patients suffering from other bleeding diseases
- PWH without written consent
- PWH \< 18 years of age
- Secondary osteoporosis
Key Trial Info
Start Date :
August 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04524481
Start Date
August 19 2020
End Date
March 1 2023
Last Update
October 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Bonn
Bonn, Northrhine Westfalia, Germany, 53127